larotrectinib
bayer
['larotrectinib']
larotrectinib continues to demonstrate high dcr, elicit durable responses in trk fusion+ cns tumors #asco22 #oncology #medtwitter 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.